Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer

By          

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 840-844

Spandidos Publications

Access to resources Recommend Favorite

Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?

By Paludan Merete   Traberg Hansen Anders   Petersen Jørgen   Grau Cai   Høyer Morten  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 818-822

Informa Healthcare

Access to resources Recommend Favorite

Particle therapy: a suitable alternative to stereotactic body radiotherapy for stage I non-small-cell lung cancer?

By Shibamoto Yuta  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 353-356

Future Medicine

Access to resources Recommend Favorite

Developments in stereotactic ablative radiotherapy for the treatment of early-stage lung cancer

By Westover Kenneth D   Timmerman Robert  

Lung Cancer Management, Vol. 2, Iss. 2, 2013-04 ,pp. : 129-139

Future Medicine

Access to resources Recommend Favorite

Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience

By Hiraoka Masahiro   Nagata Yasushi  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 352-355

Springer Publishing Company

Access to resources Recommend Favorite